|
|
 |
|
Viewing report
|
|
|
|
Joint British Societies’ Guidelines on Prevention of CVD in Clinical Practice (JBS 2)
Just Medical Media, July 2006, Pages: 8
Despite all the efforts to reduce cardiovascular risk, CVD remains the leading cause of premature death and disability in the UK. The second JBS guidelines, published in December 2005, were designed “to promote a consistent, multidisciplinary approach to managing patients with established atherosclerotic CVD and those at high risk of developing symptomatic atherosclerotic disease”.
The JBS 2 guidelines emphasise a total risk approach to CVD risk assessment in the asymptomatic population and define lifestyle and risk factor interventions with thresholds and targets that reflect the growing scientific evidence base for managing people at high risk.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Molecular Diagnostics - Technologies, Markets and Companies
Nitric Oxide - Therapeutics, Markets and Companies
Medical Review Criteria Guidelines for Managing Care (11th edition, 2012)
Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011
The Incidence and Prevalence Database: Global Incidence, Prevalence, Morbidity, Comorbidity, Cost Data, Symptoms and Many Other Health Issues for over 4,700 Diseases and Procedures
Innovations in In-Vitro Diagnostics - New Technologies, Growth Opportunities, and the Future Market Outlook
Clinical Challenges in Lipid Disorders
Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010
Innovations in Diabetes Management with Food and Drinks: Key Ingredients, NPD, Emerging Business Models and Leading Innovators
Advances in Imaging Biomarkers: Innovative Technologies, Applications in R&D and Clinical Practice, and Informatics and Regulatory Requirements
|
|
|
|
